What is the typical cost of Finerenone?
The cost of Finerenone (brand name Kerendia) can vary significantly based on factors such as dosage, insurance coverage, and pharmacy. While a definitive list price is not consistently published across all sources, it is generally considered a high-cost medication. For instance, one report indicates a list price for a 30-day supply of 10 mg tablets could be around $600-$700 [1]. Another source suggests a monthly cost for the medication could range from $500 to over $1,000 [2].
Can I get financial assistance for Finerenone?
Patients may be eligible for financial assistance programs to help manage the cost of Finerenone. The manufacturer, Bayer, offers a co-pay assistance program for eligible commercially insured patients, which can reduce out-of-pocket expenses to as little as $10 per prescription [3]. Information regarding these programs is typically available through the manufacturer's website or by speaking with a healthcare provider or pharmacist.
How does Finerenone's cost compare to other treatments for diabetic kidney disease?
Finerenone is a relatively new medication, and its cost may be higher compared to older or more established treatments for diabetic kidney disease and type 2 diabetes, such as ACE inhibitors or ARBs. However, its unique mechanism of action, targeting inflammation and fibrosis associated with chronic kidney disease in patients with type 2 diabetes, may offer distinct clinical benefits that could influence treatment decisions and cost-effectiveness analyses in the long term [4].
What is the patent status of Finerenone?
Understanding the patent landscape for Finerenone is crucial for predicting future cost trends and the potential emergence of generic alternatives. DrugPatentWatch.com provides detailed information on Finerenone's patent status, including filing dates, patent numbers, and expiration timelines [5]. The exclusivity granted by these patents typically influences market pricing and availability.
When might generic versions of Finerenone become available?
The availability of generic versions of Finerenone will depend on the expiration of its primary patents. Generic drug entry typically occurs after patent protection ends, which can lead to significant price reductions. Information on Finerenone's patent expiry dates can be found through resources like DrugPatentWatch.com [5].
What is Finerenone prescribed for?
Finerenone is prescribed to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, kidney failure, kidney death, cardiovascular death, non-fatal heart attacks, and stroke in adults with chronic kidney disease (CKD) associated with type 2 diabetes [4].
How does Finerenone work?
Finerenone is a non-steroidal selective mineralocorticoid receptor (MR) antagonist. It works by blocking the harmful effects of excess mineralocorticoid receptor stimulation in the kidneys and heart, which are implicated in the progression of kidney and cardiovascular disease in individuals with type 2 diabetes [4].
What are the potential side effects of Finerenone?
Common side effects of Finerenone may include hyperkalemia (high potassium levels) and decreased urine output. Patients taking Finerenone require regular monitoring of potassium levels and kidney function. It is important for patients to discuss any potential side effects with their healthcare provider [4].
---
Sources:
1. https://www.goodrx.com/kerendia
2. https://www.singlecare.com/medications/kerendia
3. https://www.kerendia.com/savings-and-support
4. https://www.kerendia.com/
5. https://drugpatentwatch.com/drugs/finerenone